Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. Mai 2015 20:28 ET | Quelle: Fennec Pharmaceuticals Inc.

Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 28, 2015) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF) today announced that the nominees listed in the management proxy...
15. Mai 2015 07:00 ET | Quelle: Fennec Pharmaceuticals Inc.

Fennec Provides Corporate Update and First Quarter Ended March 31, 2015 Financial Results

RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 15, 2015) - Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF), a specialty pharmaceutical company focused on the development of...
14. Mai 2015 06:00 ET | Quelle: Fennec Pharmaceuticals, Inc.

Fennec Announces Availability of Siopel 6 Study Abstract for ASCO 2015 Meeting

RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 14, 2015) - Fennec Pharmaceuticals, Inc. (TSX:FRX)(OTCQB:FENCF), today announced that sodium thiosulfate (STS) will be featured...
04. Mai 2015 07:00 ET | Quelle: Fennec Pharmaceuticals, Inc.

Fennec Pharmaceuticals Announces the Exercise of Warrants by the Company's Largest Shareholder and Provides Updated Corporate Capital Structure

RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwired - May 4, 2015) - Fennec Pharmaceuticals, Inc. (TSX:FRX)(OTCQB:FENCF), today reported that Southpoint Master Fund, LP ("Southpoint"),...
29. April 2015 13:32 ET | Quelle: Southpoint Master Fund, LP

Southpoint Files Early Warning Report in Connection With Exercise of Warrants in Fennec Pharmaceuticals Inc.

TORONTO, ONTARIO--(Marketwired - April 29, 2015) - Southpoint Master Fund, LP ("Southpoint") has acquired, by the exercise of 293,511 warrants of Fennec Pharmaceuticals Inc. ("Fennec") at...

Vorherige Seite